These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 27618277)

  • 41. Effectiveness of pseudoephedrine as adjunctive therapy for neurogenic shock after acute spinal cord injury: a case series.
    Wood GC; Boucher AB; Johnson JL; Wisniewski JN; Magnotti LJ; Croce MA; Swanson JM; Boucher BA; Fabian TC
    Pharmacotherapy; 2014 Jan; 34(1):89-93. PubMed ID: 23918202
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Is Thrombocytopenia an Early Prognostic Marker in Septic Shock?
    Thiery-Antier N; Binquet C; Vinault S; Meziani F; Boisramé-Helms J; Quenot JP;
    Crit Care Med; 2016 Apr; 44(4):764-72. PubMed ID: 26670473
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fluconazole improves survival in septic shock: a randomized double-blind prospective study.
    Jacobs S; Price Evans DA; Tariq M; Al Omar NF
    Crit Care Med; 2003 Jul; 31(7):1938-46. PubMed ID: 12847386
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rescue therapy with polymyxin B hemoperfusion in high-dose vasopressor therapy refractory septic shock.
    Monti G; Terzi V; Calini A; Di Marco F; Cruz D; Pulici M; Brioschi P; Vesconi S; Fumagalli R; Casella G
    Minerva Anestesiol; 2015 May; 81(5):516-25. PubMed ID: 25319136
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association between inotrope treatment and 90-day mortality in patients with septic shock.
    Wilkman E; Kaukonen KM; Pettilä V; Kuitunen A; Varpula M
    Acta Anaesthesiol Scand; 2013 Apr; 57(4):431-42. PubMed ID: 23298252
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Postoperative polymyxin B hemoperfusion and mortality in patients with abdominal septic shock: a propensity-matched analysis.
    Iwagami M; Yasunaga H; Doi K; Horiguchi H; Fushimi K; Matsubara T; Yahagi N; Noiri E
    Crit Care Med; 2014 May; 42(5):1187-93. PubMed ID: 24365858
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acute renal failure in patients with severe sepsis and septic shock--a significant independent risk factor for mortality: results from the German Prevalence Study.
    Oppert M; Engel C; Brunkhorst FM; Bogatsch H; Reinhart K; Frei U; Eckardt KU; Loeffler M; John S;
    Nephrol Dial Transplant; 2008 Mar; 23(3):904-9. PubMed ID: 18065435
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diastolic arterial blood pressure: a reliable early predictor of survival in human septic shock.
    Benchekroune S; Karpati PC; Berton C; Nathan C; Mateo J; Chaara M; Riché F; Laisné MJ; Payen D; Mebazaa A
    J Trauma; 2008 May; 64(5):1188-95. PubMed ID: 18469640
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cardiac troponin I predicts myocardial dysfunction and adverse outcome in septic shock.
    Mehta NJ; Khan IA; Gupta V; Jani K; Gowda RM; Smith PR
    Int J Cardiol; 2004 May; 95(1):13-7. PubMed ID: 15159032
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock.
    Kumar A; Roberts D; Wood KE; Light B; Parrillo JE; Sharma S; Suppes R; Feinstein D; Zanotti S; Taiberg L; Gurka D; Kumar A; Cheang M
    Crit Care Med; 2006 Jun; 34(6):1589-96. PubMed ID: 16625125
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Survival in neutropenic patients with severe sepsis or septic shock.
    Legrand M; Max A; Peigne V; Mariotte E; Canet E; Debrumetz A; Lemiale V; Seguin A; Darmon M; Schlemmer B; Azoulay E
    Crit Care Med; 2012 Jan; 40(1):43-9. PubMed ID: 21926615
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).
    Watson D; Grover R; Anzueto A; Lorente J; Smithies M; Bellomo R; Guntupalli K; Grossman S; Donaldson J; Le Gall JR;
    Crit Care Med; 2004 Jan; 32(1):13-20. PubMed ID: 14707555
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Targeted tissue perfusion versus macrocirculation-guided standard care in patients with septic shock (TARTARE-2S): study protocol and statistical analysis plan for a randomized controlled trial.
    Pettilä V; Merz T; Wilkman E; Perner A; Karlsson S; Lange T; Hästbacka J; Hjortrup PB; Kuitunen A; Jakob SM; Takala J
    Trials; 2016 Aug; 17():384. PubMed ID: 27484695
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mortality trends in U.S. adults with septic shock, 2005-2011: a serial cross-sectional analysis of nationally-representative data.
    Goto T; Yoshida K; Tsugawa Y; Filbin MR; Camargo CA; Hasegawa K
    BMC Infect Dis; 2016 Jun; 16():294. PubMed ID: 27301657
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy of therapy with recombinant human activated protein C of critically ill surgical patients with infection complicated by septic shock and multiple organ dysfunction syndrome.
    Barie PS; Hydo LJ; Shou J; Eachempati SR
    Surg Infect (Larchmt); 2011 Dec; 12(6):443-9. PubMed ID: 22185191
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Septic shock in chronic dialysis patients: clinical characteristics, antimicrobial therapy and mortality.
    Clark E; Kumar A; Langote A; Lapinsky S; Dodek P; Kramer A; Wood G; Bagshaw SM; Wood K; Gurka D; Sood MM;
    Intensive Care Med; 2016 Feb; 42(2):222-32. PubMed ID: 26607816
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [A clinical study of pituitrin versus norepinephrine in the treatment of patients with septic shock].
    Han XD; Sun H; Huang XY; Zhang SY; Wang YD; Ren K; Li F
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 Jan; 24(1):33-7. PubMed ID: 22248749
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial.
    Annane D; Vignon P; Renault A; Bollaert PE; Charpentier C; Martin C; Troché G; Ricard JD; Nitenberg G; Papazian L; Azoulay E; Bellissant E;
    Lancet; 2007 Aug; 370(9588):676-84. PubMed ID: 17720019
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of chronic hypertension on time to goal mean arterial pressure and clinical outcomes in critically ill patients with septic shock requiring vasopressors.
    Yeo QM; Hammond DA; Li C; Olsen KM
    J Crit Care; 2019 Feb; 49():143-148. PubMed ID: 30428412
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Resuscitation bundle compliance in severe sepsis and septic shock: improves survival, is better late than never.
    Coba V; Whitmill M; Mooney R; Horst HM; Brandt MM; Digiovine B; Mlynarek M; McLellan B; Boleski G; Yang J; Conway W; Jordan J;
    J Intensive Care Med; 2011; 26(5):304-13. PubMed ID: 21220270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.